Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets

Trends in Parasitology - Tập 17 Số 11 - Trang 532-537 - 2001
Graham H. Coombs1, Daniel E. Goldberg2, Michael Klemba2, Colin Berry3, John Kay3, Jeremy C. Mottram1
1University of Glasgow, Glasgow, UK G12 8QQ
2Howard Hughes Medical Institute, Washington University, St. Louis, MO 63110, USA.
3Cardiff University, Cardiff, UK CF10 3US

Tóm tắt

Từ khóa


Tài liệu tham khảo

Coombs, 1997, Parasite proteinases and amino acid metabolism: possibilities for chemotherapeutic exploitation, Parasitology, 114, S61, 10.1017/S003118209700111X

Rosenthal, 1999, Proteases of protozoan parasites, Adv. Parasitol., 43, 105, 10.1016/S0065-308X(08)60242-0

Tomasselli, 2000, Targeting the HIV-protease in AIDS therapy: a current clinical perspective, Biochim. Biophys. Acta, 1477, 189, 10.1016/S0167-4838(99)00273-3

Wlodawer, 1998, Inhibitors of HIV protease: a major success of structure-assisted drug design, Annu. Rev. Biophys. Biomol. Struct., 27, 249, 10.1146/annurev.biophys.27.1.249

Hoegl, 1999, Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age, Pharmazie, 54, 319

Oefner, 1999, Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?, Chem. Biol., 6, 127, 10.1016/S1074-5521(99)89004-8

Dunn, 2000, The two sides of enzyme-substrate specificity: lessons from the aspartic proteinases, Biochim. Biophys. Acta, 1477, 231, 10.1016/S0167-4838(99)00275-7

Eggelson, 1999, Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum, J. Biol. Chem., 274, 32411, 10.1074/jbc.274.45.32411

Kolakovich, 1997, Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production, Mol. Biochem. Parasitol., 87, 123, 10.1016/S0166-6851(97)00062-5

Francis, 1997, Hemoglobin metabolism in Plasmodium, Ann. Rev. Microbiol., 51, 97, 10.1146/annurev.micro.51.1.97

Francis, 1994, Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase, EMBO J., 13, 306, 10.1002/j.1460-2075.1994.tb06263.x

Moon, 1997, Expression and characterisation of plasmepsin I from Plasmodium falciparum, Eur. J. Biochem., 244, 552, 10.1111/j.1432-1033.1997.00552.x

Gluzman, 1994, Order and specificity in the Plasmodium falciparum hemoglobin degradation pathway, J. Clin. Invest., 93, 1602, 10.1172/JCI117140

Pasvol, 1977, Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum, Nature, 270, 171, 10.1038/270171a0

Shear, 1998, Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism, Blood, 92, 2520, 10.1182/blood.V92.7.2520

Francis, 1997, Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II, J. Biol. Chem., 272, 14961, 10.1074/jbc.272.23.14961

Silva, 1996, Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum, Proc. Natl. Acad. Sci. U. S. A., 93, 10034, 10.1073/pnas.93.19.10034

Binggeli, A. et al. (1996) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency. World (PCT) Patent WO 9709311–A1

Hill, 1994, High level expression and characterisation of plasmepsin II, an aspartic proteinase from Plasmodium falciparum, FEBS Lett., 352, 155, 10.1016/0014-5793(94)00940-6

Luker, 1996, Kinetic analysis of plasmepsins I and II, aspartic proteases of the Plasmodium falciparum digestive vacuole, Mol. Biochem. Parasitol., 79, 71, 10.1016/0166-6851(96)02651-5

Tyas, 1999, Naturally-occurring and recombinant forms of Plasmepsins I and II from the human malaria parasite Plasmodium falciparum, FEBS Lett., 454, 210, 10.1016/S0014-5793(99)00805-4

Westling, 1999, Active site specificity of plasmepsin II, Protein Sci., 8, 2001, 10.1110/ps.8.10.2001

Haque, 1999, Potent, low molecular weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II, J. Med. Chem., 42, 1428, 10.1021/jm980641t

Humphreys, 1999, The aspartic proteinase from the rodent parasite Plasmodium berghei as a potential model for plasmepsins from the human malaria parasite, Plasmodium falciparum, FEBS Lett., 463, 43, 10.1016/S0014-5793(99)01597-5

Berry, 1999, A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparum, FEBS Lett., 447, 149, 10.1016/S0014-5793(99)00276-8

Vassar, 2000, β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science, 286, 735, 10.1126/science.286.5440.735

Redmond, 2001, Expression of Haemonchus contortus pepsinogen in Caenorhabditis elegans, Mol. Biochem. Parasitol., 112, 125, 10.1016/S0166-6851(00)00357-1

Brindley, 2001, Proteolysis of human hemoglobin by schistosome cathepsin D, Mol. Biochem. Parasitol., 112, 103, 10.1016/S0166-6851(00)00351-0

Jolodar, 1997, Preliminary characterisation of an Onchocerca volvulus aspartic protease, Int. J. Parasitol., 27, 1087, 10.1016/S0020-7519(97)00069-6

Harrop, 1996, Acasp, a gene encoding a cathepsin D-like aspartic protease from the hookworm Ancylostoma caninum, Biochem Biophys. Res. Commun., 227, 294, 10.1006/bbrc.1996.1503

Laha, 2001, Gulliver, a long terminal repeat retrotransposon from the genome of the oriental blood fluke Schistosoma japonicum, Gene, 264, 59, 10.1016/S0378-1119(00)00601-6

Laurent, 1993, Cloning and characterisation of an Eimeria acervulina sporozoite gene homologous to aspartyl proteinases, Mol. Biochem. Parasitol., 62, 303, 10.1016/0166-6851(93)90119-I

Jean, 2000, Differential localisation of an Eimeria tenella aspartyl proteinase during the infection process, Int. J. Parasitol., 30, 1099, 10.1016/S0020-7519(00)00099-0

Shenai, 2000, Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum, J. Biol. Chem., 275, 29000, 10.1074/jbc.M004459200

Semenov, 1998, Antimalarial synergy of cysteine and aspartic protease inhibitors, Antimicrob. Agents Chemother., 42, 2254, 10.1128/AAC.42.9.2254

Saftig, 1995, Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal-mucosa and profound destruction of lymphoid-cells, EMBO J., 14, 3599, 10.1002/j.1460-2075.1995.tb00029.x

Tatnell, 1998, Napsins: new human aspartic proteinases. Distinction between two closely related genes, FEBS Lett., 441, 43, 10.1016/S0014-5793(98)01522-1

Bennett, 2000, Expression analysis of BACE2 in brain and peripheral tissues, J. Biol. Chem., 275, 20647, 10.1074/jbc.M002688200

Meijerink, 1993, Gastric chief cell-specific transcription of the pepsinogen A gene, Eur. J. Biochem., 213, 67, 10.1111/j.1432-1033.1993.tb17880.x

Reid, 1984, Identification of the acid proteinase in human seminal fluid as a gastricsin originating in the prostate, Cell Tissue Res., 236, 597, 10.1007/BF00217228

Sealey, 1989, Prorenin and renin as separate mediatiors of tissue and circulating systems, Am. J. Hypertens., 2, 358, 10.1093/ajh/2.5.358

Tatnell, 1997, Cathepsin E, 283